InsidersTradesSigma
쓰리빌리언 Stock: price and insider trades · South Korea · DART (FSS)
Track the 쓰리빌리언 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has recorded 33 reports. Market capitalisation: €166.1bn. The latest transaction was disclosed on 26 May 2026 (Purchase). Among the most active insiders: 한국산업은행. All data is openly available.
33
Insider Decl.
n/a
Thresholds
n/a
25 ops.
Buy Volume
n/a
6 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,846 of 28,199 companies
32.6
score / 100
Value26
Quality39
FCF yld-3.0%
Earn yld-2.8%
EV/EBITDA·
ROE-21%
Gross mgn100%
Net mgn-46%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 May 2026
Declarations33 total
1,509,827 sharesKRXDART:20260109000362
25 of 33 declarations
About 쓰리빌리언
쓰리빌리언 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.